Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
nanoparticles
Biotech
Genentech spends $15M to rocket into GenEdit’s NanoGalaxy
GenEdit and Genentech are partnering to develop polymer nanoparticles to enhance the delivery of gene-editing therapies for autoimmune diseases.
Max Bayer
Jan 23, 2024 7:00am
Young livers may filter out nanodrugs, stifling their efficacy
Sep 25, 2023 5:30am
NexImmune halves team as cash forces focus on core capabilities
Sep 1, 2023 6:39am
Takeda, Poseida see promising data for hemophilia A gene therapy
Dec 14, 2022 3:15pm
Scientists explore 'mosaic', inhaled COVID-19 vaccine options
Jul 7, 2022 2:34pm
Using corn to make nanoparticles that target tumors in mice
Feb 22, 2022 8:10am